AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer

Triple-negative breast cancer (TNBC) is an aggressive subset of breast carcinomas that lack expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2). Unlike other breast cancer subtypes, targeted therapy is presently unavailable for patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Wei, Li, Jieqing, Hao, Qiongyu, Vadgama, Jaydutt V, Wu, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385460/
https://www.ncbi.nlm.nih.gov/pubmed/30791936
http://dx.doi.org/10.1186/s13058-019-1107-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385460/
https://www.ncbi.nlm.nih.gov/pubmed/30791936
http://dx.doi.org/10.1186/s13058-019-1107-2

Ejemplares similares